# AI_MODEL_BIAS_SURVEILLENCE.md

## Document Purpose
This document defines the mandatory bias surveillance, detection, evaluation, and remediation framework for all AI models operating within the NeuroGrid ecosystem. It ensures continuous compliance with clinical safety, ethical integrity, and cross-jurisdictional regulatory expectations (FDA, EU AI Act, GDPR, LGPD, HIPAA-aligned).

Bias surveillance is treated as a **continuous safety obligation**, not a one-time validation exercise.

---

## Scope
Applies to:
- All clinical AI models (active, shadow, or retired)
- RPM signal interpretation models
- Risk stratification, alerting, and decision-support models
- Any AI component influencing clinician-facing outputs

Excludes:
- Non-clinical administrative automation
- Static rule-based systems without learned parameters

---

## Regulatory Alignment
This policy aligns with:
- FDA GMLP (Good Machine Learning Practice)
- EU AI Act (High-Risk AI – bias & representativeness)
- ISO/IEC 24028 (AI Trustworthiness)
- OECD AI Principles (Fairness & Accountability)
- WHO AI in Health Guidance

---

## Bias Risk Taxonomy

### 1. Demographic Bias
Unequal model performance across:
- Age groups
- Sex / gender
- Ethnicity / ancestry
- Socioeconomic proxies (where legally permissible)
- Geographic region

### 2. Clinical Bias
- Underperformance on specific comorbidities
- Skewed outputs for rare diseases
- Training data overrepresentation of specific cohorts

### 3. Data Collection Bias
- Device variability (RPM hardware differences)
- Signal degradation in certain populations
- Sampling frequency inconsistencies

### 4. Temporal Bias
- Model drift over time
- Changing population baselines
- Post-deployment epidemiological shifts

---

## Surveillance Architecture

### Continuous Monitoring Layers

| Layer | Description |
|-----|------------|
| Pre-deployment | Bias assessment during validation |
| Post-deployment | Live performance stratification |
| Periodic Audit | Scheduled deep bias audits |
| Event-triggered | Triggered by alerts, complaints, or anomalies |

Bias surveillance **must operate independently** of model optimization pipelines.

---

## Mandatory Bias Metrics

### Performance Stratification
For each protected or clinically relevant subgroup:
- Sensitivity
- Specificity
- PPV / NPV
- False positive rate
- False negative rate

### Threshold Rules
- Any subgroup deviation > **±5–10%** (context-dependent) from baseline requires investigation
- Clinically critical use-cases may enforce stricter thresholds

Threshold values must be documented in the **AI Model Safety Case**.

---

## Detection & Flagging Triggers

Bias review is automatically initiated when:
- Subgroup performance breach is detected
- Clinician override rates cluster by subgroup
- Alert suppression or escalation patterns diverge
- External complaint or regulatory inquiry is received
- Data distribution shift exceeds defined tolerance

---

## Governance & Accountability

### Responsible Roles

| Role | Responsibility |
|----|----------------|
| Model Owner | Bias mitigation execution |
| Clinical Safety Lead | Clinical impact assessment |
| Ethics Committee | Ethical risk evaluation |
| DAO Oversight (Constrained) | Transparency & audit traceability |
| Compliance Officer | Regulatory reporting |

Bias decisions **cannot be overridden** by token-weighted governance.

---

## Remediation Pathways

Approved remediation actions include:
- Dataset rebalancing
- Model retraining with documented changes
- Threshold adjustment (clinically justified only)
- Model scope restriction
- Temporary suspension or rollback

All remediation actions must:
- Preserve historical audit logs
- Be versioned
- Update downstream documentation

---

## Transparency & Disclosure

### Internal Disclosure
- Bias findings recorded in model audit logs
- Accessible to clinicians and auditors
- Linked to Safety Case and Confidence Thresholds

### External Disclosure
- Aggregate, anonymized bias metrics
- Published via Public Transparency Dashboard
- Individual-level data never disclosed

---

## Clinician Interaction
- Bias indicators must **never** be hidden from clinicians
- Confidence and uncertainty communication must reflect known bias risks
- Clinician disagreement logs are reviewed for bias signal amplification

---

## Prohibited Practices
- Silent bias mitigation without documentation
- Performance optimization that worsens subgroup safety
- DAO voting on bias acceptability
- Suppressing bias findings for reputational reasons

---

## Review Cycle

| Activity | Frequency |
|--------|-----------|
| Automated monitoring | Continuous |
| Formal bias audit | Quarterly (minimum) |
| Regulatory alignment review | Annually |
| Post-incident review | Immediate |

---

## Enforcement
Failure to comply with this policy results in:
- Immediate model suspension (if safety-relevant)
- Governance escalation
- Regulatory notification where required

Bias surveillance is a **clinical safety function**, not a research optimization feature.

---

## Status
**Active – Mandatory – Non-Optional**

---
End of document.

